Cargando…
Glutathione S-transferase M1-null genotype as risk factor for SOS in oxaliplatin-treated patients with metastatic colorectal cancer
BACKGROUND: Oxaliplatin is used as a neo-adjuvant therapy in hepatic colorectal carcinoma metastasis. This treatment has significant side effects, as oxaliplatin is toxic to the sinusoidal endothelial cells and can induce sinusoidal obstruction syndrome (SOS), which is related to decreased overall s...
Autores principales: | Vreuls, C P H, Olde Damink, S W M, Koek, G H, Winstanley, A, Wisse, E, Cloots, R H E, van den Broek, M A J, Dejong, C H C, Bosman, F T, Driessen, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593549/ https://www.ncbi.nlm.nih.gov/pubmed/23287989 http://dx.doi.org/10.1038/bjc.2012.590 |
Ejemplares similares
-
T (null )and M (null )genotypes of the glutathione S-transferase gene are risk factor for CAD independent of smoking
por: Abu-Amero, Khaled K, et al.
Publicado: (2006) -
Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS) – novel predictors for response and survival in gastric cancer patients
por: Goekkurt, E, et al.
Publicado: (2006) -
Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases
por: van den Broek, Maartje A. J., et al.
Publicado: (2009) -
Null genotypes of glutathione S-transferase μ1 and glutathione S-transferase θ1 are associated with osteosarcoma risk: A meta-analysis
por: HAN, JICHENG, et al.
Publicado: (2015) -
Fat causes necrosis and inflammation in parenchymal cells in human steatotic liver
por: Wisse, Eddie, et al.
Publicado: (2021)